These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8437623

  • 21. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.
    DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J.
    J Immunol; 1997 Mar 01; 158(5):2183-91. PubMed ID: 9036964
    [Abstract] [Full Text] [Related]

  • 22. Peptide binding by class I and class II MHC molecules.
    Batalia MA, Collins EJ.
    Biopolymers; 1997 Mar 01; 43(4):281-302. PubMed ID: 9316393
    [Abstract] [Full Text] [Related]

  • 23. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S, Trembleau S, Penna G, Gallazzi F, Hammer J, Papadopoulos GK, Adorini L.
    J Immunol; 1999 Jun 01; 162(11):6630-40. PubMed ID: 10352280
    [Abstract] [Full Text] [Related]

  • 24. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T, Kasselman JP, Ford SR, Murray JS.
    Cell Immunol; 1996 Mar 15; 168(2):193-200. PubMed ID: 8640865
    [Abstract] [Full Text] [Related]

  • 25. Natural killer cell recognition of HLA class I molecules.
    Brooks AG, Boyington JC, Sun PD.
    Rev Immunogenet; 2000 Mar 15; 2(3):433-48. PubMed ID: 11256749
    [Abstract] [Full Text] [Related]

  • 26. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH, Freeman JD, Mager DL, Takei F.
    J Immunol; 1998 Sep 01; 161(5):2301-6. PubMed ID: 9725224
    [Abstract] [Full Text] [Related]

  • 27. Design and use of conditional MHC class I ligands.
    Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, van de Kasteele W, Rimmelzwaan GF, Haanen JB, Ovaa H, Schumacher TN.
    Nat Med; 2006 Feb 01; 12(2):246-51. PubMed ID: 16462803
    [Abstract] [Full Text] [Related]

  • 28. Structural implications for the design of molecular vaccines.
    Apostolopoulos V, Yu M, McKenzie IF, Wilson IA.
    Curr Opin Mol Ther; 2000 Feb 01; 2(1):29-36. PubMed ID: 11249650
    [Abstract] [Full Text] [Related]

  • 29. Biochemical analysis of an MHC-linked hematopoietic cell surface antigen, Qa-2.
    Soloski MJ, Vitetta ES, Flaherty L, Uhr JW.
    J Supramol Struct Cell Biochem; 1981 Feb 01; 16(2):167-77. PubMed ID: 7299842
    [Abstract] [Full Text] [Related]

  • 30. Peptides naturally presented by MHC class I molecules.
    Rammensee HG, Falk K, Rötzschke O.
    Annu Rev Immunol; 1993 Feb 01; 11():213-44. PubMed ID: 8476560
    [Abstract] [Full Text] [Related]

  • 31. Decrypting class I MHC-bound peptides with peptide libraries.
    Udaka K.
    Trends Biochem Sci; 1996 Jan 01; 21(1):7-11. PubMed ID: 8848840
    [Abstract] [Full Text] [Related]

  • 32. Thermostability analysis of major histocompatibility complex class I molecules by temperature gradient gel electrophoresis.
    Tulp A, Verwoerd DJ.
    Eur J Immunol; 1993 Aug 01; 23(8):2030-3. PubMed ID: 8344370
    [Abstract] [Full Text] [Related]

  • 33. Differential role of conserved and polymorphic residues of the binding groove of MHC class I molecules in the selection of peptides.
    Abastado JP, Casrouge A, Kourilsky P.
    J Immunol; 1993 Oct 01; 151(7):3569-75. PubMed ID: 8376793
    [Abstract] [Full Text] [Related]

  • 34. Chemistry of peptides associated with MHC class I and class II molecules.
    Rammensee HG.
    Curr Opin Immunol; 1995 Feb 01; 7(1):85-96. PubMed ID: 7772286
    [Abstract] [Full Text] [Related]

  • 35. Multiple sequence analysis: pool sequencing of synthetic and natural peptide libraries.
    Stevanović S, Jung G.
    Anal Biochem; 1993 Jul 01; 212(1):212-20. PubMed ID: 8368496
    [Abstract] [Full Text] [Related]

  • 36. The Qa-1 alloantigens. III. Biochemical analysis of the structure and extent of polymorphism of the Qa-1 allelic products.
    Landolfi NF, Rich RR, Cook RG.
    J Immunol; 1985 Aug 01; 135(2):1264-70. PubMed ID: 3925004
    [Abstract] [Full Text] [Related]

  • 37. A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides.
    Joyce S, Tabaczewski P, Angeletti RH, Nathenson SG, Stroynowski I.
    J Exp Med; 1994 Feb 01; 179(2):579-88. PubMed ID: 8294869
    [Abstract] [Full Text] [Related]

  • 38. Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.
    Chen L, Reyes-Vargas E, Dai H, Escobar H, Rudd B, Fairbanks J, Ho A, Cusick MF, Kumánovics A, Delgado J, He X, Jensen PE.
    J Immunol; 2014 Aug 01; 193(3):1427-39. PubMed ID: 24958902
    [Abstract] [Full Text] [Related]

  • 39. Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide.
    Ying G, Wang J, Kumar V, Zajonc DM.
    PLoS One; 2017 Aug 01; 12(8):e0182296. PubMed ID: 28767728
    [Abstract] [Full Text] [Related]

  • 40. Qa-1b binds conserved class I leader peptides derived from several mammalian species.
    Kurepa Z, Hasemann CA, Forman J.
    J Exp Med; 1998 Sep 07; 188(5):973-8. PubMed ID: 9730898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.